Latest
 
  • All Share : 50507.59
    UNCHANGED0.00%
    Top 40 : 3738.95
    UNCHANGED0.00%
    Financial 15 : 15605.51
    UNCHANGED0.00%
    Industrial 25 : 61994.65
    UNCHANGED0.00%

  • ZAR/USD : 10.9691
    UP 0.20%
    ZAR/GBP : 17.2200
    UP 0.07%
    ZAR/EUR : 13.6766
    UP 0.11%
    ZAR/JPY : 0.0931
    UP 0.13%
    ZAR/AUD : 9.3645
    DOWN -0.03%

  • Gold : 1199.5250
    DOWN -0.13%
    Platinum : 1220.5000
    UP 0.04%
    Silver : 16.6350
    DOWN -0.10%
    Palladium : 794.0000
    UP 0.76%
    Brent Crude Oil : 78.310
    DOWN -0.03%

  • All data is delayed by 15 min. Data supplied by I-Net Bridge
    Hover cursor over this ticker to pause.

Send Mail

Melanoma drug nearly doubles survival time: study

A new drug to treat advanced skin cancer, or metastatic melanoma, has been shown to nearly double average survival time in a study of more than 130 patients, researchers said.

AFP Relaxnews

 24 February, 2012 10:45
* Required